Benefits of Osteopathic Manual Therapy for Patients with Respiratory Illness
Official title: OMT and Respiratory Illness
Run by Geisinger Clinic · NCT06495021 · Data updated 2026-11-12
This study is testing if adding Osteopathic Manual Therapy to standard care can help older patients with respiratory illnesses like pneumonia and bronchitis feel better faster.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 65 Years to 100 Years |
| Sex | All |
| Enrollment | 68 (estimated) |
| Sponsor | Geisinger Clinic Academic / other |
| Locations | 1 site (Bloomsburg, Pennsylvania) |
| Status | Recruiting |
| Started | December 31, 2024 |
| Main results expected | December 31, 2026 |
| Study ends | May 31, 2027 |
| Registry record updated | August 11, 2026 |
| Trial ID | NCT06495021 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are patients aged 65-100 who have recently been diagnosed with upper respiratory illnesses during their outpatient visit.
✕Probably not a fit
Patients with active cancer treatment, healing fractures, or liver disease may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study investigates the effectiveness of Osteopathic Manipulative Therapy (OMT) in treating newly diagnosed patients with respiratory illnesses such as pneumonia, sinusitis, and bronchitis. The approach combines OMT with standard care to determine if it can alleviate symptoms more quickly and reduce the duration of the illness. The study is conducted at the Geisinger 65-Forward clinic in Buckhorn, PA, targeting patients aged 65-100. Previous research has indicated potential benefits of OMT in similar contexts, but this study aims to quantify those improvements in an outpatient setting.
Why it matters
Potential benefit: If successful, this study could provide a low-cost, effective treatment option that enhances recovery from respiratory illnesses.
How similar studies have gone: Previous studies have shown benefits of OMT in various models, but this specific outpatient approach is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients being seen for respiratory illness symptoms at Geisinger 65-Forward Buckhorn, PA clinic for care. * Patients age of 65-100 * New diagnosis of upper respiratory illness, sinusitis, bronchitis, or pneumonia during outpatient visit. Exclusion Criteria: * Patients that have a healing fracture, including the spine, pelvis, shoulder, ribs, vertebrae, or extremities. * Patients actively receiving any type of cancer treatment * Patients with active or previously diagnosed liver disease.
Where it's running
-
Geisinger 65-Forward, Buckhorn
Bloomsburg, Pennsylvania, United States Recruiting
Study contacts
- Principal investigator: Margaret Moore, DO — Physician
- Study coordinator: Margaret Moore, DO
- Email: Mmoore9@geisinger.edu
- Phone: (570) 416-5435
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Respiratory Physiotherapy in Critically Ill Pneumonia Patients
This study tests whether a structured breathing and chest therapy program can change inflammatory biomarkers in adults with pneumonia in the ICU compared to usual care.
-
AI-powered CT help to guide pneumonia care
A multicenter trial tests whether using a chest CT–based AI report to guide care reduces death or need for new organ support in adults with pneumonia.
-
Wintergreen oil inhalation for shortness of breath in pneumonia patients
Hospitals will test whether inhaling wintergreen essential oil helps relieve dyspnea in adults with pneumonia.
-
Optimising Antibiotic Use for Paediatric LRTIs in Africa
This study tests whether using point-of-care CRP tests together with the PREPARE score can safely reduce antibiotic use in infants aged 2–24 months with lower respiratory infections in a Johannesburg hospital.
-
Baloxavir for preventing flu after exposure in household contacts
A single dose of baloxavir marboxil is being tested to see if it prevents symptomatic, lab-confirmed influenza in people who live with someone who has flu symptoms.
-
Buteyko Breathing vs Incentive Spirometry for Smog-Induced Pneumonia
We’re testing whether the Buteyko Breathing Technique can improve oxygen levels and breathe easier for adults with smog-related pneumonia compared to incentive spirometry.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.